The US mammography market is projected to grow at a significant CAGR of around 8.6% during the forecast period (2021-2027). The market for mammography in the US is projected to driven due to growing R&D activities by the market players in the country. Numerous market players are conducting R&D of new products for breast cancer screening. For instance, in December 2019, Paragon Biosciences LLC, located in Chicago, US, established Qlarity Imaging LLC, US, and announced its plans to develop QuantX, the innovative US FDA-cleared computer-aided breast cancer diagnosis system in radiology. Thus, the development of such technologies will advance imaging techniques for breast cancer that further provide a significant opportunity to the market in the near future.
To Request a Sample of our Report on US mammography Market: https://www.omrglobal.com/request-sample/us-mammography-market
Moreover, the supportive government programs for breast screening further provide significant growth to the market. For instance, the National Breast and Cervical Cancer Early Detection Program by the CDC provide early breast and cervical cancer screening and diagnostic services to low-income, underserved, and uninsured, women and supports strategic planning to increase screening rates in the country. In addition, a better reimbursement scenario for breast imaging technologies, such as screening and 3D mammography, is an effective measure to curtail mortality rates caused due to breast cancer. For instance, in 2019, the Centers for Medicare and Medicaid Services (CMS) announced various reimbursement rates for screening and diagnostic 3D mammography. Thus, such programs can support the diagnosis of breast cancer at the earliest stages, which encourages the growth of the mammography market in the US.
(Get 15% Discount on Buying this Report)
A full Report of US mammography Market is Available at: https://www.omrglobal.com/industry-reports/us-mammography-market
US mammography Market – Segmentation
By Product Type
· Digital Systems
· Analog Systems
· Biopsy Systems
· Film Screen System
· Others (3D Systems)
By End-User
· Hospital & Clinics
· Diagnostic Centers
(This release has been published on OMR Industry Journal. OMR Industry Journal is not responsible for any content included in this release.)
